Prosecution Insights
Last updated: July 17, 2026
Application No. 15/922,064

RESPIRATION FROM A PHOTOPLETHYSMOGRAM (PPG) USING FIXED AND ADAPTIVE FILTERING

Non-Final OA §101
Filed
Mar 15, 2018
Examiner
AGAHI, PUYA
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Nonin Medical Inc.
OA Round
7 (Non-Final)
49%
Grant Probability
Moderate
7-8
OA Rounds
0m
Est. Remaining
73%
With Interview

Examiner Intelligence

Grants 49% of resolved cases
49%
Career Allowance Rate
259 granted / 527 resolved
-20.9% vs TC avg
Strong +24% interview lift
Without
With
+24.0%
Interview Lift
resolved cases with interview
Typical timeline
4y 2m
Avg Prosecution
49 currently pending
Career history
589
Total Applications
across all art units

Statute-Specific Performance

§101
13.5%
-26.5% vs TC avg
§103
69.5%
+29.5% vs TC avg
§102
3.3%
-36.7% vs TC avg
§112
3.9%
-36.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 527 resolved cases

Office Action

§101
DETAILED ACTION Note: The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Applicant’s arguments filed in the reply on April 6, 2026 were received and fully considered. Claims 32-69 were cancelled. 70-90 are new. Please see corresponding rejection headings and response to arguments section below for more detail. Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant’s submission filed on April 6, 2026 has been entered. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 70-90 are rejected under 35 U.S.C. 101 because the claimed invention is directed to non-statutory subject matter. The claim(s) as a whole, considering all claim elements both individually and in combination, do not amount to significantly more than an abstract idea. A streamlined analysis of claim 70 follows. Regarding claim 1, the claim recites a system to determine a respiration rate of a subject. Thus, the claim is directed to a machine/product, which is one of the statutory categories of invention. The claim is then analyzed to determine whether it is directed to any judicial exception. The following limitations set forth a judicial exception: PNG media_image1.png 795 658 media_image1.png Greyscale These limitations describe a mathematical calculation. Furthermore, the limitations also describe a mental process as the skilled artisan is capable of performing the recited limitations and making a mental assessment thereafter. Examiner also notes that nothing from the claims suggest that the limitations cannot be practically performed by a human, or using simple pen/paper. Next, the claim as a whole is analyzed to determine whether any element, or combination of elements, integrates the identified judicial exception into a practical application. For this part of the 101 analysis, the following additional limitations are considered: PNG media_image2.png 211 658 media_image2.png Greyscale These additional limitations do not integrate the judicial exception into a practical application. Rather, the additional limitations are each recited at a high level of generality such that it amounts to insignificant extra-solution activity, e.g., mere data gathering steps necessary (via generically recited optically-based physiological sensor) to perform the identified judicial exception and outputting the result of a calculation do not integrate the abstract idea into a practical application. See MPEP 2106.05(g). The additional limitations also do not add significantly more to the identified judicial exception because these limitations amount to conventional techniques for obtaining widely known PPG data and utilizing a generically recited processor to perform the identified calculation and/or mental process. Dependent claims 71-90 also fail to add something more to the abstract independent claims as they merely further limit the abstract idea, recite limitations that do not integrate the claims into a practical application for substantially similar reasons as set forth above, and/or do not recite significantly more than the identified abstract idea for substantially similar reasons as set forth above. Therefore, claims 70-90 are not patent eligible under 35 USC 101. Response to Arguments Applicant's arguments filed with respect to the 35 USC 101 rejections raised in the previous office action have been fully considered, but they are not persuasive. At the onset, Examiner acknowledges that applicant’s current arguments were directed to claims that have since been cancelled. Nonetheless, Examiner remains unconvinced that new claims 70-90 recite patent eligible subject matter. As set forth in the corresponding rejection heading above, the instant claims recite an abstract idea (mathematical calculations and/or mental process) (1) that is not integrated into a practical application; and (2) the additional/structural limitations fail to recite significantly more. Furthermore, applicant cites to other cases (Ex parte Durnin, CardioNet1, McRo, etc.), none of which are persuasive in overcoming the current patent eligibility rejections. For at least these reasons, the 35 USC 101 rejections are maintained. Conclusion No claim is allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to PUYA AGAHI whose telephone number is (571)270-1906. The examiner can normally be reached M-F 8 AM - 5 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Alexander Valvis can be reached at 5712724233. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /PUYA AGAHI/Primary Examiner, Art Unit 3791 1 Appellant previously pointed to CardioNet, which the PTAB did not find persuasive upon affirming the 35 USC 101 rejection in the PTAB decision on January 29, 2026.
Read full office action

Prosecution Timeline

Show 37 earlier events
Apr 21, 2025
Response after Non-Final Action
Apr 21, 2025
Response after Non-Final Action
Jan 28, 2026
Response after Non-Final Action
Mar 12, 2026
Request for Continued Examination
Mar 19, 2026
Response after Non-Final Action
Mar 26, 2026
Examiner Interview Summary
Mar 26, 2026
Applicant Interview (Telephonic)
Apr 21, 2026
Non-Final Rejection mailed — §101 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678104
Neural Recording with Stimulus Crosstalk Compensation
3y 8m to grant Granted Jul 14, 2026
Patent 12672858
COMPOSITIONS, DEVICES AND METHODS FOR TESTING INANIMATE SURFACES, GROUPS AND INDIVIDUALS FOR PATHOGEN INFECTION
3y 7m to grant Granted Jul 07, 2026
Patent 12648713
A DEVICE AND METHOD TO DETERMINE THE MEAN/AVERAGE CONTROL OF ASTHMA/COPD OVER TIME AND COMPLIANCE TO TREATMENT
6y 0m to grant Granted Jun 09, 2026
Patent 12635905
EXHALED BREATH CONDENSATE COLLECTION DEVICE AND A KIT OF PARTS THEREFOR
4y 1m to grant Granted May 26, 2026
Patent 12629066
USE OF SENSOR REDUNDANCY TO DETECT SENSOR FAILURES
5y 5m to grant Granted May 19, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

7-8
Expected OA Rounds
49%
Grant Probability
73%
With Interview (+24.0%)
4y 2m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 527 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month